vs
德纳（DAN）与NEUROCRINE BIOSCIENCES INC（NBIX）财务数据对比。点击上方公司名可切换其他公司
德纳的季度营收约是NEUROCRINE BIOSCIENCES INC的1.6倍（$1.3B vs $805.5M），NEUROCRINE BIOSCIENCES INC净利率更高（19.1% vs -3.9%，领先22.9%），NEUROCRINE BIOSCIENCES INC同比增速更快（28.3% vs -44.5%），NEUROCRINE BIOSCIENCES INC自由现金流更多（$386.0M vs $345.0M），过去两年NEUROCRINE BIOSCIENCES INC的营收复合增速更高（25.0% vs -31.2%）
德纳（Dana Inc.）是美国知名汽车零部件供应商，创立于1904年，总部位于俄亥俄州莫米。公司为传统燃油车、混合动力车及电动车提供车桥、传动轴，以及电驱动、热管理、密封、数字设备等产品，服务于轻型车、商用车市场，业务遍及33个国家，员工近2.8万人，2022年销售额达102亿美元，位列财富世界500强。
Neurocrine Biosciences是1992年成立的美国生物制药企业，总部位于加利福尼亚州圣地亚哥，截至2024年10月首席执行官为Kyle Gano。公司专注于神经及内分泌相关疾病的疗法研发，旗下药物缬苯那嗪（商品名Ingrezza）于2017年获美国批准，用于治疗成人迟发性运动障碍。
DAN vs NBIX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $805.5M |
| 净利润 | $-50.0M | $153.7M |
| 毛利率 | 6.0% | 97.8% |
| 营业利润率 | -0.2% | 26.2% |
| 净利率 | -3.9% | 19.1% |
| 营收同比 | -44.5% | 28.3% |
| 净利润同比 | 37.5% | 49.1% |
| 每股收益（稀释后） | $-0.36 | $1.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $1.3B | $805.5M | ||
| Q3 25 | $1.9B | $794.9M | ||
| Q2 25 | $1.9B | $687.5M | ||
| Q1 25 | $2.4B | $572.6M | ||
| Q4 24 | $2.3B | $627.7M | ||
| Q3 24 | $2.5B | $622.1M | ||
| Q2 24 | $2.7B | $590.2M | ||
| Q1 24 | $2.7B | $515.3M |
| Q4 25 | $-50.0M | $153.7M | ||
| Q3 25 | $83.0M | $209.5M | ||
| Q2 25 | $27.0M | $107.5M | ||
| Q1 25 | $25.0M | $7.9M | ||
| Q4 24 | $-80.0M | $103.1M | ||
| Q3 24 | $4.0M | $129.8M | ||
| Q2 24 | $16.0M | $65.0M | ||
| Q1 24 | $3.0M | $43.4M |
| Q4 25 | 6.0% | 97.8% | ||
| Q3 25 | 8.7% | 98.2% | ||
| Q2 25 | 7.1% | 98.4% | ||
| Q1 25 | 9.4% | 98.4% | ||
| Q4 24 | 5.7% | 98.5% | ||
| Q3 24 | 9.9% | 98.7% | ||
| Q2 24 | 9.3% | 98.4% | ||
| Q1 24 | 8.9% | 98.5% |
| Q4 25 | -0.2% | 26.2% | ||
| Q3 25 | 2.8% | 30.1% | ||
| Q2 25 | 0.8% | 21.2% | ||
| Q1 25 | 3.1% | 4.1% | ||
| Q4 24 | -1.5% | 22.6% | ||
| Q3 24 | 3.6% | 29.5% | ||
| Q2 24 | 3.8% | 24.6% | ||
| Q1 24 | 2.6% | 19.3% |
| Q4 25 | -3.9% | 19.1% | ||
| Q3 25 | 4.3% | 26.4% | ||
| Q2 25 | 1.4% | 15.6% | ||
| Q1 25 | 1.1% | 1.4% | ||
| Q4 24 | -3.4% | 16.4% | ||
| Q3 24 | 0.2% | 20.9% | ||
| Q2 24 | 0.6% | 11.0% | ||
| Q1 24 | 0.1% | 8.4% |
| Q4 25 | $-0.36 | $1.49 | ||
| Q3 25 | $0.64 | $2.04 | ||
| Q2 25 | $0.19 | $1.06 | ||
| Q1 25 | $0.17 | $0.08 | ||
| Q4 24 | $-0.55 | $1.00 | ||
| Q3 24 | $0.03 | $1.24 | ||
| Q2 24 | $0.11 | $0.63 | ||
| Q1 24 | $0.02 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $469.0M | $713.0M |
| 总债务越低越好 | $2.6B | — |
| 股东权益账面价值 | $840.0M | $3.3B |
| 总资产 | $7.8B | $4.6B |
| 负债/权益比越低杠杆越低 | 3.05× | — |
8季度趋势，按日历期对齐
| Q4 25 | $469.0M | $713.0M | ||
| Q3 25 | $414.0M | $340.2M | ||
| Q2 25 | $486.0M | $264.0M | ||
| Q1 25 | $507.0M | $194.1M | ||
| Q4 24 | $494.0M | $233.0M | ||
| Q3 24 | $419.0M | $349.1M | ||
| Q2 24 | $419.0M | $139.7M | ||
| Q1 24 | $351.0M | $396.3M |
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.6B | — |
| Q4 25 | $840.0M | $3.3B | ||
| Q3 25 | $1.1B | $3.0B | ||
| Q2 25 | $1.2B | $2.7B | ||
| Q1 25 | $1.4B | $2.5B | ||
| Q4 24 | $1.3B | $2.6B | ||
| Q3 24 | $1.5B | $2.7B | ||
| Q2 24 | $1.5B | $2.5B | ||
| Q1 24 | $1.5B | $2.4B |
| Q4 25 | $7.8B | $4.6B | ||
| Q3 25 | $8.1B | $4.3B | ||
| Q2 25 | $8.1B | $3.9B | ||
| Q1 25 | $7.8B | $3.7B | ||
| Q4 24 | $7.5B | $3.7B | ||
| Q3 24 | $7.9B | $3.5B | ||
| Q2 24 | $7.8B | $3.3B | ||
| Q1 24 | $7.9B | $3.5B |
| Q4 25 | 3.05× | — | ||
| Q3 25 | 2.35× | — | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 1.76× | — | ||
| Q4 24 | 1.79× | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 1.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $406.0M | $388.4M |
| 自由现金流经营现金流 - 资本支出 | $345.0M | $386.0M |
| 自由现金流率自由现金流/营收 | 26.6% | 47.9% |
| 资本支出强度资本支出/营收 | 4.7% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 2.53× |
| 过去12个月自由现金流最近4个季度 | $298.0M | $743.9M |
8季度趋势，按日历期对齐
| Q4 25 | $406.0M | $388.4M | ||
| Q3 25 | $111.0M | $227.5M | ||
| Q2 25 | $32.0M | $102.0M | ||
| Q1 25 | $-37.0M | $64.8M | ||
| Q4 24 | $302.0M | $242.5M | ||
| Q3 24 | $35.0M | $158.0M | ||
| Q2 24 | $215.0M | $64.6M | ||
| Q1 24 | $-102.0M | $130.3M |
| Q4 25 | $345.0M | $386.0M | ||
| Q3 25 | $62.0M | $214.3M | ||
| Q2 25 | $3.0M | $89.5M | ||
| Q1 25 | $-112.0M | $54.1M | ||
| Q4 24 | $149.0M | $235.2M | ||
| Q3 24 | $-11.0M | $149.9M | ||
| Q2 24 | $104.0M | $53.0M | ||
| Q1 24 | $-172.0M | $119.1M |
| Q4 25 | 26.6% | 47.9% | ||
| Q3 25 | 3.2% | 27.0% | ||
| Q2 25 | 0.2% | 13.0% | ||
| Q1 25 | -4.8% | 9.4% | ||
| Q4 24 | 6.4% | 37.5% | ||
| Q3 24 | -0.4% | 24.1% | ||
| Q2 24 | 3.8% | 9.0% | ||
| Q1 24 | -6.3% | 23.1% |
| Q4 25 | 4.7% | 0.3% | ||
| Q3 25 | 2.6% | 1.7% | ||
| Q2 25 | 1.5% | 1.8% | ||
| Q1 25 | 3.2% | 1.9% | ||
| Q4 24 | 6.6% | 1.2% | ||
| Q3 24 | 1.9% | 1.3% | ||
| Q2 24 | 4.1% | 2.0% | ||
| Q1 24 | 2.6% | 2.2% |
| Q4 25 | — | 2.53× | ||
| Q3 25 | 1.34× | 1.09× | ||
| Q2 25 | 1.19× | 0.95× | ||
| Q1 25 | -1.48× | 8.20× | ||
| Q4 24 | — | 2.35× | ||
| Q3 24 | 8.75× | 1.22× | ||
| Q2 24 | 13.44× | 0.99× | ||
| Q1 24 | -34.00× | 3.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAN
| Light Vehicle Segment | $912.0M | 70% |
| Commercial Vehicle Segment | $218.0M | 17% |
| Other | $166.0M | 13% |
NBIX
| INGREZZA Net Product Sales | $653.8M | 81% |
| CRENESSITY Net Product Sales | $135.4M | 17% |
| Other Income | $12.6M | 2% |
| Collaboration Revenue | $7.2M | 1% |
